← Open Payments lookup

KASSIANI KELLEHER: Open Payments

NPI 1124709829 · HIAWATHA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$676 in 35 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $676

Food & beverage: $676
CompanyPaymentsAmount
ABBVIE INC.13$228
Otsuka America Pharmaceutical, Inc.9$178
Vanda Pharmaceuticals Inc.3$61
E.R. Squibb & Sons, L.L.C.3$59
Neurocrine BioSciences, Inc.2$53
Teva Pharmaceuticals USA, Inc.2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Corium, LLC1$28

Products named: VRAYLAR, REXULTI, FANAPT, COBENFY, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, CAPLYTA.

Industry payments across IA — which companies pay providers there.